Volume 24, Issue 163 (1-2018)
RJMS 2018, 24(163): 63-69 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kianmehr N. Update in Systemic Lupus Erythematosus. RJMS 2018; 24 (163) :63-69
URL: http://rjms.iums.ac.ir/article-1-4842-en.html
URL: http://rjms.iums.ac.ir/article-1-4842-en.html
Iran University of Medical Sciences, Tehran, Iran , kianmehrnahid@gmail.com
Abstract: (4211 Views)
Systemic Lupus Erythematosus (SLE) is a chronic, life threatening systemic disorder that may affect multiple organs in the body. Dysfunction of the immune system, leading to over production of antibodies and immune complexes cause wide arrays of clinical feature. The classification criteria of SLE were updated in 2012. Treatment of SLE is individualized based on severity and extent of organ involvement. Nowadays, treat to target approach makes much more medications available and holds much more promise on the management of SLE.
Type of Study: review article |
Subject:
Rheumatology
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
